AstraZeneca PLC (UK) Price History
| AZN Stock | 10,938 94.00 0.87% |
Below is the normalized historical share price chart for AstraZeneca PLC extending back to June 03, 1993. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of AstraZeneca PLC stands at 10,938, as last reported on the 18th of January 2025, with the highest price reaching 11,122 and the lowest price hitting 10,910 during the day.
If you're considering investing in AstraZeneca Stock, it is important to understand the factors that can impact its price. AstraZeneca PLC secures Sharpe Ratio (or Efficiency) of -0.0738, which signifies that the company had a -0.0738% return per unit of risk over the last 3 months. AstraZeneca PLC exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AstraZeneca PLC's Risk Adjusted Performance of (0.05), standard deviation of 1.65, and Mean Deviation of 1.08 to double-check the risk estimate we provide.
At present, AstraZeneca PLC's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 296 M, whereas Common Stock is forecasted to decline to about 297.3 M. . AstraZeneca Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of May 1993 | 200 Day MA 11.7 K | 50 Day MA 10.4 K | Beta 0.18 |
AstraZeneca |
Sharpe Ratio = -0.0738
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AZN |
Estimated Market Risk
| 1.67 actual daily | 14 86% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average AstraZeneca PLC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AstraZeneca PLC by adding AstraZeneca PLC to a well-diversified portfolio.
Price Book 5.0552 | Enterprise Value Ebitda 15.636 | Price Sales 3.3121 | Shares Float 1.5 B | Dividend Share 2.97 |
AstraZeneca PLC Stock Price History Chart
There are several ways to analyze AstraZeneca Stock price data. The simplest method is using a basic AstraZeneca candlestick price chart, which shows AstraZeneca PLC price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 23, 2024 | 11828.0 |
| Lowest Price | November 7, 2024 | 9725.0 |
AstraZeneca PLC January 18, 2025 Stock Price Synopsis
Various analyses of AstraZeneca PLC's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell AstraZeneca Stock. It can be used to describe the percentage change in the price of AstraZeneca PLC from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of AstraZeneca Stock.| AstraZeneca PLC Price Rate Of Daily Change | 1.01 | |
| AstraZeneca PLC Price Action Indicator | (31.00) | |
| AstraZeneca PLC Price Daily Balance Of Power | 0.44 |
AstraZeneca PLC January 18, 2025 Stock Price Analysis
AstraZeneca Stock Price History Data
The price series of AstraZeneca PLC for the period between Sun, Oct 20, 2024 and Sat, Jan 18, 2025 has a statistical range of 2299.0 with a coefficient of variation of 5.52. The prices are distributed with arithmetic mean of 10706.26. The median price for the last 90 days is 10594.0. The company issued dividends on 2024-08-08.| Open | High | Low | Close | Volume | ||
01/18/2025 | 10,950 | 11,122 | 10,910 | 10,938 | ||
| 01/17/2025 | 10,950 | 11,122 | 10,910 | 10,938 | 1,700,135 | |
| 01/16/2025 | 10,728 | 10,844 | 10,722 | 10,844 | 1,097,151 | |
| 01/15/2025 | 10,628 | 10,674 | 10,577 | 10,648 | 1,593,197 | |
| 01/14/2025 | 10,768 | 10,826 | 10,586 | 10,630 | 1,194,558 | |
| 01/13/2025 | 10,900 | 10,934 | 10,794 | 10,822 | 1,063,619 | |
| 01/10/2025 | 10,980 | 11,008 | 10,900 | 10,982 | 1,054,126 | |
| 01/09/2025 | 10,806 | 11,000 | 10,778 | 10,988 | 1,149,640 | |
| 01/08/2025 | 10,664 | 10,768 | 10,612 | 10,754 | 1,061,939 | |
| 01/07/2025 | 10,598 | 10,714 | 10,526 | 10,668 | 1,182,077 | |
| 01/06/2025 | 10,552 | 10,730 | 10,552 | 10,712 | 1,187,290 | |
| 01/03/2025 | 10,656 | 10,708 | 10,594 | 10,594 | 894,401 | |
| 01/02/2025 | 10,406 | 10,650 | 10,402 | 10,630 | 676,738 | |
| 12/31/2024 | 10,334 | 10,470 | 10,319 | 10,468 | 373,178 | |
| 12/30/2024 | 10,450 | 10,482 | 10,360 | 10,408 | 731,996 | |
| 12/27/2024 | 10,454 | 10,460 | 10,360 | 10,460 | 1,016,394 | |
| 12/24/2024 | 10,478 | 10,498 | 10,436 | 10,436 | 754,278 | |
| 12/23/2024 | 10,308 | 10,466 | 10,304 | 10,422 | 1,208,720 | |
| 12/20/2024 | 10,222 | 10,280 | 10,084 | 10,256 | 3,826,293 | |
| 12/19/2024 | 10,276 | 10,308 | 10,165 | 10,244 | 1,195,731 | |
| 12/18/2024 | 10,482 | 10,508 | 10,324 | 10,352 | 3,565,541 | |
| 12/17/2024 | 10,384 | 10,532 | 10,350 | 10,506 | 1,782,000 | |
| 12/16/2024 | 10,520 | 10,606 | 10,482 | 10,524 | 1,308,256 | |
| 12/13/2024 | 10,546 | 10,554 | 10,435 | 10,468 | 2,011,964 | |
| 12/12/2024 | 10,544 | 10,576 | 10,468 | 10,568 | 1,257,405 | |
| 12/11/2024 | 10,494 | 10,586 | 10,440 | 10,538 | 3,047,915 | |
| 12/10/2024 | 10,650 | 10,698 | 10,508 | 10,512 | 1,069,796 | |
| 12/09/2024 | 10,694 | 10,736 | 10,596 | 10,702 | 1,349,725 | |
| 12/06/2024 | 10,622 | 10,734 | 10,608 | 10,654 | 1,347,094 | |
| 12/05/2024 | 10,514 | 10,636 | 10,480 | 10,618 | 1,458,917 | |
| 12/04/2024 | 10,684 | 10,686 | 10,422 | 10,480 | 4,022,133 | |
| 12/03/2024 | 10,584 | 10,802 | 10,570 | 10,790 | 1,609,472 | |
| 12/02/2024 | 10,596 | 10,646 | 10,534 | 10,554 | 1,227,108 | |
| 11/29/2024 | 10,568 | 10,613 | 10,532 | 10,612 | 2,368,698 | |
| 11/28/2024 | 10,636 | 10,654 | 10,572 | 10,594 | 915,994 | |
| 11/27/2024 | 10,526 | 10,546 | 10,424 | 10,532 | 1,338,197 | |
| 11/26/2024 | 10,532 | 10,564 | 10,408 | 10,492 | 1,562,267 | |
| 11/25/2024 | 10,484 | 10,546 | 10,404 | 10,474 | 5,509,465 | |
| 11/22/2024 | 10,184 | 10,548 | 10,140 | 10,474 | 1,998,086 | |
| 11/21/2024 | 9,867 | 10,088 | 9,866 | 10,062 | 5,438,001 | |
| 11/20/2024 | 10,088 | 10,154 | 9,958 | 9,969 | 1,864,052 | |
| 11/19/2024 | 9,960 | 10,034 | 9,921 | 10,024 | 1,493,209 | |
| 11/18/2024 | 9,920 | 9,945 | 9,844 | 9,915 | 2,001,951 | |
| 11/15/2024 | 10,114 | 10,148 | 9,943 | 9,978 | 2,801,070 | |
| 11/14/2024 | 10,148 | 10,304 | 10,094 | 10,292 | 2,399,269 | |
| 11/13/2024 | 10,238 | 10,308 | 10,076 | 10,144 | 2,013,801 | |
| 11/12/2024 | 10,290 | 10,290 | 9,746 | 9,990 | 2,910,124 | |
| 11/11/2024 | 9,965 | 10,047 | 9,940 | 9,985 | 1,861,668 | |
| 11/08/2024 | 9,846 | 10,008 | 9,806 | 9,903 | 2,711,147 | |
| 11/07/2024 | 9,891 | 9,900 | 9,670 | 9,725 | 5,398,731 | |
| 11/06/2024 | 10,330 | 10,379 | 9,869 | 9,922 | 5,368,499 | |
| 11/05/2024 | 11,044 | 11,052 | 10,010 | 10,114 | 4,208,204 | |
| 11/04/2024 | 11,016 | 11,342 | 10,930 | 11,042 | 1,328,108 | |
| 11/01/2024 | 11,068 | 11,114 | 11,002 | 11,022 | 1,852,478 | |
| 10/31/2024 | 11,160 | 11,165 | 10,986 | 11,042 | 2,331,963 | |
| 10/30/2024 | 11,486 | 11,540 | 10,898 | 11,206 | 3,359,764 | |
| 10/29/2024 | 11,676 | 11,714 | 11,534 | 11,534 | 1,678,378 | |
| 10/28/2024 | 11,604 | 11,638 | 11,476 | 11,628 | 960,153 | |
| 10/25/2024 | 11,690 | 11,716 | 11,560 | 11,606 | 1,281,189 | |
| 10/24/2024 | 11,852 | 11,870 | 11,688 | 11,696 | 1,008,759 | |
| 10/23/2024 | 11,856 | 11,914 | 11,822 | 11,828 | 726,618 |
About AstraZeneca PLC Stock history
AstraZeneca PLC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for AstraZeneca is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in AstraZeneca PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing AstraZeneca PLC stock prices may prove useful in developing a viable investing in AstraZeneca PLC
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.8 B | 1.4 B | |
| Net Income Applicable To Common Shares | 3 B | 3.2 B |
AstraZeneca PLC Stock Technical Analysis
AstraZeneca PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
AstraZeneca PLC Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for AstraZeneca PLC's price direction in advance. Along with the technical and fundamental analysis of AstraZeneca Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of AstraZeneca to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.16) | |||
| Treynor Ratio | (73.49) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for AstraZeneca Stock analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |